
LONDON, Aug 27 (Reuters) - Google has agreed to settle a mass London lawsuit brought on behalf of app developers for £260 million ($353.21 million), according to a deal published on Thursday.
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

LONDON, Aug 27 (Reuters) - Google has agreed to settle a mass London lawsuit brought on behalf of app developers for £260 million ($353.21 million), according to a deal published on Thursday.

BEIJING, Aug 27 () - Chinese regulators on Thursday ordered automakers to file proactive recall plans for any defects uncovered in self-audits, as part of a year-long campaign to improve vehicle quality and safety in the world's largest auto market. Tesla and eight Chinese electric vehicle makers on August 21 announced fixes affecting a combined 4.

Pennsylvania’s Attorney General has sued Snap Inc., alleging that Snapchat misleads parents about mature content and uses design features that encourage compulsive use among minors, and is seeking civil penalties and changes to how the platform is marketed and accessed. Beyond the legal exposure, the case goes to the heart of Snap’s engagement model by questioning features like Snapstreaks, infinite scroll and Friend Solar System that help shape user behavior, especially for younger...

On Aug. 26, 2026, a cyberattack halted order processing and shipping at the medical device maker, leaving investors uncertain about the speed of recovery and near-term shipment delays.

Daraxonrasib, the pill touted by a former member of Congress and cancer patient as a ‘miracle drug,’ has been granted approval in patients with pancreatic adenocarcinoma.
Meta just settled one of the largest state attorney general cases in tech history, and the stock did not move. Jim Cramer has a theory about why investors treated a major legal victory like it never happened.

The lawsuit alleged that Meta knowingly designed platforms like Instagram and Facebook to addict children, despite knowing about the harms the platforms could pose to young users.

The U.S. Food and Drug Administration (FDA) on Tuesday approved Abbott Laboratories’ (NYSE:ABT) Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for diabetes patients aged two and older. The regulatory nod makes the device the first wearable in the U.S. to monitor ketone levels continuously. It also represents the first global system to track blood sugar and ketones simultaneously within a single unit. Clinical Data And De Novo Pathway The agency granted marketing authorization
The software remedy may contain repair costs, but the recall reaches far beyond one quarter of deliveries.

JNJ's Imaavy wins FDA approval for wAIHA, becoming the first treatment specifically indicated for the rare autoimmune disease.

Over 4 million vehicles are being recalled.

JPMorgan Chase (NYSE:JPM) and Morgan Stanley are facing ongoing shareholder lawsuits tied to recent multibillion dollar buyout deals that took public companies private. The complaints allege the banks facilitated undervalued sales to private equity buyers and breached fiduciary duties in their advisory roles. These cases are testing the scope of legal protections for large banks involved in M&A transactions under evolving corporate law. Investors are watching the proceedings for potential...

Super Micro Computer has cleared a major governance hurdle. Is the stock a 'Buy' now?

Intuit (NasdaqGS: INTU) and several top executives face a new class action lawsuit alleging they misled investors about generative AI competition and Mailchimp performance. The complaint claims Intuit understated the competitive threat from generative AI tools and misrepresented trends in Mailchimp's business. Plaintiffs have expanded the suit to cover a longer class period, building on earlier litigation focused on similar issues. The case raises fresh questions about Intuit's disclosures...

The Food and Drug Administration cleared a blood test for identifying Alzheimer’s disease symptoms, which was developed by Roche and Eli Lilly.

Tesla Inc. is recalling 2.98 million vehicles in China, its largest recall ever in the country, because passengers may be unable to find and use the emergency door releases after a crash cuts power. Bloomberg has identified at least 15...

Tesla (NasdaqGS:TSLA) is recalling nearly 3 million vehicles in China due to potential safety issues with emergency door releases. The recall is the company’s largest in China to date and affects vehicles already on Chinese roads. Separately, Tesla has introduced a new Powerwall home battery leasing plan as competition in residential energy storage increases. The recall and the Powerwall shift could influence how regulators, consumers and investors view Tesla’s broader business model. This...
(Updated with response from Meta spokesperson in the seventh paragraph.) Meta Platforms (META), A

Oura rings are popular tools for measuring how well Americans sleep. A new lawsuit alleges, however, that much of the data is really hogwash.
(Updated with response from Google spokesperson in sixth paragraph.) Meta Platforms (META), Alpha
Nearly 1 million vehicles under review after 499 complaints
Millions of vehicles need software fixes tied to safety concerns.

Tesla Inc. (NASDAQ:TSLA) is recalling 2.98 million vehicles in China, its largest recall ever in the country, because passengers may be unable to find and use the emergency door releases after a crash cuts power. Bloomberg has identified at least...
(Updated with response from Snap spokesperson in fifth paragraph.) Meta Platforms (META), Alphabe
Meta Platforms (META), Alphabet's (GOOGL) Google and Snap (SNAP) face one fewer teen social media ad

The AI-hardware maker’s board found no evidence CEO Charles Liang knew anything about alleged chip smuggling but a pending trial could bring more legal exposure to the beleaguered company.

Super Micro says its internal probe has cleared current management of any wrongdoing. But does that warrant buying SMCI shares today? Let’s find out!

AST SpaceMobile (NasdaqGS:ASTS) has been sued by Delclaux Partners over more than US$15 million in disputed contractual finder’s fees. The lawsuit centers on alleged unpaid compensation linked to financing arrangements that Delclaux Partners claims it helped source. The case raises questions about AST SpaceMobile’s contractual obligations and potential financial and reputational risks. This kind of legal and financing friction is not unique to AST SpaceMobile. It can be useful to compare...
SMCI said its investigation also found no evidence that Supermicro directly sold export-controlled products to known restricted parties or locations.

In August 2026, Regeneron Pharmaceuticals announced that the US FDA approved Pasatru (garetosmab-grts) to reduce new heterotopic ossification lesions and flare-ups in adults with fibrodysplasia ossificans progressiva, based on positive Phase 3 OPTIMA trial results. This approval adds a rare-disease monoclonal antibody to Regeneron’s portfolio, reinforcing the company’s focus on specialized, high-complexity immunology therapies. We’ll now examine how Pasatru’s FOP approval, as an ultra-rare...
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.